Since Christopher Nolan's 'Oppenheimer' took the Academy Award for Best Picture, there's no doubt that people's curiosity has ...

Peter Oppenheimer, chief global equity strategist at Goldman Sachs, says the prospect of looser monetary and fiscal policy in ...

Related: "It Was Not Right": Shailene Woodley Broke Her Silence About The Aaron Rodgers Breakup ...

Oppenheimer downgraded Prothena Corporation plc (NASDAQ: PRTA) to Perform from Outperform on May 27 without a price target.

Fintel reports that on May 27, 2025, Oppenheimer downgraded their outlook for Prothena (NasdaqGS:PRTA) from Outperform to ...

Follow along here for live updates on the AI chip giant's quarterly results, as well as market reaction and comments from ...

Looking for biopics to binge-watch this weekend? Here're 10 must-watch biographical films on Netflix that tell stories of ...

The season 2 finale, of course, ends with a tense cliffhanger and some tragic conclusion, and it leaves fans eagerly craving ...

Prothena (PRTA) stock drops as a late-stage trial for the company's lead candidate fails, prompting Oppenheimer and Jefferies ...

Salesforce is scheduled to report fiscal first-quarter results after the closing bell Wednesday, with analysts largely ...

Plaintiffs seek reversal of an ordinance prohibiting wake-enhanced boating on four lakes in in Burnett County, as well as damages.

On Thursday, Oppenheimer raised its price target on Snowflake Inc. (NYSE: SNOW) to $225 from $210, while maintaining an ...